Downloads

Downloads

Current Presentations

Date Title File
Jan 13, 2025
Immatics Corporate Presentation January 2025
Nov 18, 2024
TCR Bispecific Molecule TCER® IMA402 Targeting PRAME - Phase 1 Dose Escalation Clinical Data Update
Nov 08, 2024
ACTengine® IMA203 TCR-T Targeting PRAME Shows Deep and Durable Anti-Tumor Activity in Heavily Pretreated Solid Cancer Patients
Nov 08, 2024
Enhanced Pharmacology Data of Next-generation IMA203CD8 TCR-T Monotherapy Targeting PRAME
Nov 08, 2024
Combination of a TCR-engineered Autologous PRAME-targeting T Cell Therapy with a PRAME-encoding mRNA for the Treatment of Solid Tumors
Sep 16, 2024
TCER® IMA401 Targeting MAGEA4/8 - Phase 1 Dose Escalation Clinical Data Update
Nov 10, 2022
Next-generation TCER® Format Presentation at SITC Annual Meeting, November 2022
Nov 10, 2022
PRAME Target Presentation at SITC Annual Meeting, November 2022
Sep 10, 2022
TCER IMA402 Preclinical Data Update Presentation at ESMO, September 2022
Nov 12, 2021
Next-generation CD8ab TCR-T approach - Preclinical Data Update at SITC Annual Meeting, November 2021

Archive

Date Title File
Nov 10, 2020
Immatics ACTolog® IMA101 Phase-1-Data at the 35th Annual SITC conference

Media Materials